Search results for “Schizophreniform disorder” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 95 patents, we discovered top 29 key players by total patent application. Newron Pharmaceuticals SpA, Eli Lilly & Co., Intra-Cellular Therapies, Inc. are dominant in this area. They take 32.63% of the total patent filing.
Lombardia, Italy
Patent: 13
Indiana, United States
Patent: 10
New York, United States
Patent: 8
Maharashtra, India
Patent: 8
Noord-Holland, Netherlands
Patent: 7
New York, United States
Patent: 5
New Jersey, United States
Patent: 4
Illinois, United States
Patent: 3
Tokyo-to, Japan
Patent: 3
Hounslow, United Kingdom
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 3 patents applied in the last 5 years. We discover 2 most active companies in this area.
New York, United States
Patent: 2
New York, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
No data, please try another search term
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: